Fulgent ( FLGT ) Q2 Revenue Jumps 16%
Fulgent Genetics ( NASDAQ:FLGT ) , a genomic testing company focused on precision diagnostics and therapeutic development, reported better-than-expected results in its Q2 2025 earnings release dated August 1, 2025. The company posted GAAP revenue of $81.8 million, comfortably surpassing the ...
Why Fulgent Genetics Stock Was Crushing It on Friday
The next-generation diagnostics specialist had a beat-and-raise second quarter.
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday - Rich Sparkle Holdings ( NASDAQ:ANPA ) , AppFolio ( NASDAQ:APPF )
U.S. stocks were lower, with the Dow Jones index falling around 500 points on Friday. Shares of Monolithic Power Systems, Inc. MPWR rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above ...
Fulgent Genetics, Inc. ( FLGT ) Surpasses Q2 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +130.43% and +7.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm - Adtran Holdings ( NASDAQ:ADTN ) , Fulgent Genetics ( NASDAQ:FLGT )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler ( SMLR ) , GoHealth ( GOCO ) , Adtran ( ADTN ) , or Fulgent ( FLGT ) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Abacus, GoHealth, and Fulgent and Encourages Investors to Contact the Firm - Fulgent Genetics ( NASDAQ:FLGT ) , Abacus Global Management ( NASDAQ:ABL )
NEW YORK, June 30, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. GOCO, Semler Scientific Inc. SMLR, Fulgent Genetics, Inc. FLGT, and Abacus Global Management, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, June 23, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ( "Fulgent" or the "Company" ) FLGT. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm - Adtran Holdings ( NASDAQ:ADTN ) , Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, June 09, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Semler Scientific Inc. SMLR, ADTRAN Holdings, Inc. ADTN, and Fulgent Genetics, Inc.
Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm - Adtran Holdings ( NASDAQ:ADTN ) , Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EchoStar Corporation SATS, Semler Scientific Inc. SMLR, ADTRAN Holdings, Inc. ADTN, and Fulgent Genetics, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ( "Fulgent" or the "Company" ) FLGT. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. ( NASDAQ: FLGT ) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Fulgent Genetics ( NASDAQ:FLGT )
NEWTOWN, Pa., May 28, 2025 ( GLOBE NEWSWIRE ) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Fulgent Genetics, Inc. ( "Fulgent" ) FLGT, resulting from allegations of providing potentially misleading business information to the investing ...
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. ( "Fulgent" or the "Company" ) FLGT on behalf of Fulgent stockholders.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. ( "Fulgent" or the "Company" ) FLGT. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, May 16, 2025 ( GLOBE NEWSWIRE ) -- Wolf Haldenstein Adler Freeman & Herz LLP ( "Wolf Haldenstein" ) , a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fulgent Genetics, Inc. FLGT.
Fulgent Genetics, Inc. ( FLGT ) Q1 Earnings and Revenues Beat Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 121.05% and 2.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health ( HIMS ) Moves 5.7% Higher: Will This Strength Last?
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 - Alaska Air Gr ( NYSE:ALK ) , Ambac Financial Group ( NYSE:AMBC )
NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ( "S&P DJI" ) will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance.
Fulgent Genetics Revenue Tops Estimates
Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.
Fulgent Genetics, Inc. ( FLGT ) Q4 Earnings and Revenues Beat Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 133.33% and 1.90%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
TruBridge ( TBRG ) Soars 6.4%: Is Further Upside Left in the Stock?
TruBridge (TBRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Schrodinger ( SDGR ) Moves 14.1% Higher: Will This Strength Last?
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics ( FLGT ) : Here's What You Should Know
The mean of analysts' price targets for Fulgent Genetics (FLGT) points to a 31.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
All You Need to Know About Fulgent Genetics ( FLGT ) Rating Upgrade to Strong Buy
Fulgent Genetics (FLGT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for November 22nd
SNEX, PKG, APAM, MNDY and FLGT have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2024.
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology
Westford, USA, Nov. 22, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Gene Panel Market share will reach a value of USD 11.75 Billion by 2031, with a CAGR of 19.30% during the forecast period ( 2024-2031 ) .
Fulgent Genetics, Inc. ( FLGT ) Surpasses Q3 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 263.16% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
TruBridge ( TBRG ) Reports Q3 Loss, Tops Revenue Estimates
TruBridge (TBRG) delivered earnings and revenue surprises of -140.38% and 1.86%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics ( FLGT ) Surges 5.8%: Is This an Indication of Further Gains?
Fulgent Genetics (FLGT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Hims & Hers Health ( HIMS ) Soars 10.1%: Is Further Upside Left in the Stock?
Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Fulgent Genetics ( FLGT ) Upgraded to Buy: What Does It Mean for the Stock?
Fulgent Genetics (FLGT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
How Much Upside is Left in Fulgent Genetics ( FLGT ) ? Wall Street Analysts Think 27.22%
The mean of analysts' price targets for Fulgent Genetics (FLGT) points to a 27.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Fulgent Genetics Q2: Core Revenue Grows, but Profitability Is Still an Issue
The genetic testing company's core business is growing, but it's still generating red ink.
Fulgent Genetics, Inc. ( FLGT ) Beats Q2 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 148.39% and 3.37%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Fulgent Genetics ( FLGT ) Soars 6.6%: Is Further Upside Left in the Stock?
Fulgent Genetics (FLGT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
After promising results from first-in-man studies with its novel Neural Ice™ technology, the Massachusetts-based company will use the capital to initiate pivotal clinical studies in both chronic and acute pain indications
Fulgent Genetics, Inc. ( FLGT ) Reports Q1 Loss, Misses Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 96.97% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation ( AMWL ) Reports Q1 Loss, Misses Revenue Estimates
American Well (AMWL) delivered earnings and revenue surprises of -38.89% and 2.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Privia Health ( PRVA ) Misses Q4 Earnings Estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -60% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Health Catalyst ( HCAT ) Q4 Earnings and Revenues Beat Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of 300% and 1.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Carrier Screening Market is Expected to Reach $5.4 Billion | MarketsandMarkets™
Chicago, Feb. 15, 2024 ( GLOBE NEWSWIRE ) -- Carrier Screening market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $5.4 billion by 2028, growing at a CAGR of 19.7% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
Cooper Companies ( COO ) , Fulgent Unite to Boost Genetic Testing
Cooper Companies (COO) collaborates with Fulgent Genetics to boost newborn genetic screenings. CBR by Cooper Surgical is likely to provide a variety of genetic testing options to its families.
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire
Cord Blood Registry® ( CBR® ) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing PR ...
Four Stocks With Big Rebound Potential: The Casualty List
Buying good stocks on bad news is a sound methodology, I believe. You may not catch the exact bottom, but you're likely to find a good entry point. Each quarter, I compile a Casualty List of stocks that have been knocked down in the quarter just concluded, and that I think have excellent rebound ...
Fulgent Genetics, Inc. ( FLGT ) Reports Q3 Loss, Tops Revenue Estimates
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of -21.88% and 31.46%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Olink Holding AB ( publ ) Sponsored ADR ( OLK ) : Can Its 66.0% Jump Turn into More Strength?
Olink Holding AB (publ) Sponsored ADR (OLK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Global Hereditary Testing Market Shows Strong 8.8% CAGR, Driving Demand for Hereditary Disorder Testing Kits
New York, United States, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- Hereditary genes are either transmitted to offspring or inheritable from parents. Hereditary testing examines an individual's genome for specific hereditary variations ( variants ) .
Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock ( NYSE:BMY ) , SenesTech, Inc. - Common Stock ( NASDAQ:SNES )
On Wednesday, 311 stocks hit new 52-week lows. Bristol-Myers Squibb Company Common Stock BMY is the largest company in terms of market cap to set a new 52-week low this morning. SenesTech, Inc. - Common Stock SNES was the smallest company by market cap to set a new 52-week low. A10 Networks, ...
4 Bargain Stocks With Big Potential
The harsh market climate of August and September has left quite a few stocks selling at bargain prices. Here are four with potential to thrive.
Five Stocks That Look Enticing Based On Cash Flow
Here are five stocks that look good based on the stock price divided by the company's cash flow per share.
Why Is Fulgent Genetics Stock Moving Higher Today? - Fulgent Genetics ( NASDAQ:FLGT )
Fulgent Genetics Inc FLGT reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million. The company reported Q2 adjusted EPS loss of $ ( 0.08 ) , a turnaround from income of $0.78, beating the consensus of $ ( 0.33 ) .
